Opportunity Information: Apply for PAR 10 262
Apply for PAR 10 262
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Planning Grant for Global Infectious Disease Research Training Program (D71)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.989 International Research and Research Training.
- This funding opportunity was created on Jun 24, 2011 and posted on Aug 17, 2010.
- Applicants must submit their applications by May 21, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Public and State controlled institutions of higher education.
- Other Eligible Applicants include the following Non domestic (non U.S.) Entities (Foreign Organizations).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Planning Grant for Global Infectious Disease Research Training Program (D71) (Funding Opportunity Number PAR-10-262) is a Fogarty International Center (FIC), National Institutes of Health (NIH) planning grant designed to help applicants lay the groundwork for a future, full international research training program application under the companion D43 funding opportunity for the Global Infectious Disease Research Training Program (GID) (referenced as PAR-10-260). In practical terms, this D71 mechanism is meant to fund the early-stage planning and partnership-building work that is needed before submitting a larger, more comprehensive D43 proposal. The central expectation is that the D71 application presents a clear, credible plan to develop all key components of a competitive international infectious disease research training program, rather than operating as a stand-alone training award.
The broader GID program focus is capacity building for infectious disease research in low- and middle-income countries (LMICs), as defined by the World Bank classification system. The training emphasis is on infectious diseases other than HIV/AIDS, with the goal of strengthening the ability of LMIC institutions to conduct high-quality research that responds to local and regional disease burdens. Within that scope, FIC indicates particular interest in training programs centered on major endemic diseases, life-threatening emerging infectious diseases, neglected tropical diseases, common co-infections affecting people with HIV/AIDS (while still keeping the primary disease focus outside HIV/AIDS itself), and infections that occur in conjunction with non-communicable disease conditions associated with poverty. The announcement ties these priorities to Fogarty planning documents and broader U.S. global health priorities (including the FIC Strategic Plan and the Global Health Initiative), signaling that applicants should align proposed planning activities with these strategic directions.
A defining feature of the opportunity is its emphasis on collaboration. The planning grant is expected to be developed and carried out jointly by all designated participating institutions, reflecting the program model of international partnership and shared ownership. This implies that applicants should use the planning period to establish or deepen the institutional relationships, define roles and governance, assess training needs and research strengths, and design the training structure that would later be proposed in a D43 application. While the synopsis does not list specific required components, the intent is clearly to support the preparatory work that makes an international research training program feasible, coherent, and responsive to LMIC capacity needs.
Administratively, this is a discretionary grant in the health category, listed under CFDA 93.989 (International Research and Research Training), and it does not require cost sharing or matching. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, and non-domestic (non-U.S.) entities (foreign organizations), as clarified in the eligibility language. The opportunity was posted August 17, 2010, with an original closing date of September 21, 2012, and a current closing date listed as May 21, 2013; it was archived June 22, 2013. Additional details and the full announcement were made available through the NIH Grants Guide page linked in the notice. For access or technical issues, the contact point provided is the NIH Office of Extramural Research (OER) webmaster email listed in the announcement.
Frequently Asked Questions (FAQs)
What is the Planning Grant for Global Infectious Disease Research Training Program (D71)?
The D71 is a Fogarty International Center (FIC), National Institutes of Health (NIH) planning grant designed to support early-stage planning and partnership-building for an international infectious disease research training program.
What is the Funding Opportunity Number for this grant?
The Funding Opportunity Number is PAR-10-262.
What is the main purpose of the D71 planning grant?
The purpose is to help applicants lay the groundwork for a future, full international research training program application under the companion D43 funding opportunity for the Global Infectious Disease Research Training Program (GID) (PAR-10-260). The D71 is meant to fund preparatory work rather than operate as a stand-alone training award.
How is the D71 related to the D43 Global Infectious Disease Research Training Program (GID)?
The D71 is a planning mechanism intended to prepare applicants to submit a stronger, more comprehensive D43 proposal. In other words, D71 supports the development of the key components that would later appear in a D43 application.
Is the D71 intended to be a stand-alone training program award?
No. The central expectation is that the D71 application presents a clear and credible plan to develop all key components of a competitive international infectious disease research training program that would be proposed later under the D43 mechanism.
What is the overall program focus of the Global Infectious Disease Research Training (GID) effort?
The broader GID program focus is capacity building for infectious disease research in low- and middle-income countries (LMICs), using the World Bank classification system to define LMICs.
Which diseases and topics are emphasized for training under this program?
The training emphasis is on infectious diseases other than HIV/AIDS. Within that scope, FIC indicates particular interest in planning programs focused on major endemic diseases, life-threatening emerging infectious diseases, neglected tropical diseases, common co-infections affecting people with HIV/AIDS (while keeping the primary disease focus outside HIV/AIDS itself), and infections that occur alongside non-communicable disease conditions associated with poverty.
Does this opportunity support HIV/AIDS-focused training programs?
The primary training emphasis is on infectious diseases other than HIV/AIDS. However, the program notes interest in common co-infections affecting people with HIV/AIDS, as long as the main infectious disease focus is not HIV/AIDS itself.
Who is the sponsoring NIH component for this opportunity?
The opportunity is associated with the Fogarty International Center (FIC) at NIH.
What kinds of activities are expected during the D71 planning period?
Based on the program description, the D71 planning period is intended to support activities such as establishing or deepening institutional partnerships, defining roles and governance among participating institutions, assessing training needs and research strengths, and designing the training structure that would later be proposed as a full D43 application.
How important is collaboration to this planning grant?
Collaboration is a defining feature. The planning grant is expected to be developed and carried out jointly by all designated participating institutions, reflecting an international partnership model with shared ownership.
What geographic or country eligibility focus does the program emphasize?
The program emphasizes capacity building in low- and middle-income countries (LMICs), as defined by the World Bank classification system, with the aim of strengthening LMIC institutions' ability to conduct high-quality infectious disease research relevant to local and regional disease burdens.
What is the funding category and assistance listing information for this opportunity?
This is a discretionary grant in the health category and is listed under CFDA 93.989 (International Research and Research Training).
Is cost sharing or matching required?
No. The notice states that cost sharing or matching is not required.
Who is eligible to apply?
Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, and non-domestic (non-U.S.) entities (foreign organizations), as stated in the eligibility language provided.
When was this opportunity posted?
The opportunity was posted on August 17, 2010.
What were the closing dates for this opportunity?
The opportunity lists an original closing date of September 21, 2012, and a current closing date of May 21, 2013.
Is this funding opportunity still open?
No. It was archived on June 22, 2013.
Where could applicants find the full announcement details?
The notice indicates that additional details and the full announcement were available through the NIH Grants Guide page linked in the opportunity notice.
How should proposed planning activities align with FIC priorities?
The description ties program priorities to Fogarty planning documents and broader U.S. global health priorities (including the FIC Strategic Plan and the Global Health Initiative), suggesting that applicants should align their planned activities with these strategic directions.
Who should be contacted for access or technical issues related to the announcement?
For access or technical issues, the contact point provided is the NIH Office of Extramural Research (OER) webmaster email listed in the announcement.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Behavioral Mechanisms in Biomedical Strategies to Prevent HIV Infections (R34)
Previous opportunity: BLM OR/WA Lobster Creek Smolt Monitoring
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 10 262
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 10 262) also looked into and applied for these:
| Funding Opportunity |
|---|
| Behavioral Mechanisms in Biomedical Strategies to Prevent HIV Infections (R34) Apply for RFA MH 11 092 Funding Number: RFA MH 11 092 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Behavioral Mechanisms in Biomedical Strategies to Prevent HIV Infections (R01) Apply for RFA MH 11 090 Funding Number: RFA MH 11 090 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Behavioral Mechanisms in Biomedical Strategies to Prevent HIV Infections (R21) Apply for RFA MH 11 091 Funding Number: RFA MH 11 091 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Reinvigorating HIV Prevention for Men who have Sex with Men (R01) Apply for RFA MH 11 080 Funding Number: RFA MH 11 080 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Reinvigorating HIV Prevention for Men who have Sex with Men (R21) Apply for RFA MH 11 081 Funding Number: RFA MH 11 081 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Reinvigorating HIV Prevention for Men who have Sex with Men (R34) Apply for RFA MH 11 082 Funding Number: RFA MH 11 082 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Program to Expand and Assess the Health Effects Associated with Exposures to Volcanic Emission and Air Pollutants Apply for RFA EH08 0010301SUPP10 Funding Number: RFA EH08 0010301SUPP10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $80,000 |
| Diagnosis and Management of Severe Febrile Illness Apply for USAID TANZANIA 10 010 RFA Funding Number: USAID TANZANIA 10 010 RFA Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $24,000,000 |
| Identification of Immune Mediated Causes of Sensorineural Hearing Loss (R21/R33) Apply for RFA DC 11 002 Funding Number: RFA DC 11 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Affordable Care Act (ACA) Infrastructure to Expand Access to Care Program Apply for HRSA 11 126 Funding Number: HRSA 11 126 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Indian Health Outreach and Education Apply for HHS 2010 IHS NIHOE 0001 Funding Number: HHS 2010 IHS NIHOE 0001 Agency: Indian Health Service Category: Health Funding Amount: $340,000 |
| Support of NIGMS Program Project Grants (P01) Apply for PAR 10 266 Funding Number: PAR 10 266 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Asthma in Older Adults (R01) Apply for PA 10 263 Funding Number: PA 10 263 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Asthma in Older Adults (R21) Apply for PA 10 264 Funding Number: PA 10 264 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Asthma in Older Adults (R03) Apply for PA 10 265 Funding Number: PA 10 265 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Project Choices Pilot Implementation and Evaluation Program for American Indian and Alaska Native Women Apply for HHS 2010 IHS MHCEP 0001 Funding Number: HHS 2010 IHS MHCEP 0001 Agency: Indian Health Service Category: Health Funding Amount: $200,000 |
| NIMH Research Education Grants (R25) Apply for PAR 10 267 Funding Number: PAR 10 267 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Public Education Efforts to Increase Solid Organ Donation Apply for HRSA 11 077 Funding Number: HRSA 11 077 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Clinical Scientist Development Award in Aging (K08) Apply for RFA AG 11 008 Funding Number: RFA AG 11 008 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Paul B. Beeson Patient Oriented Research Career Development Award in Aging (K23) Apply for RFA AG 11 009 Funding Number: RFA AG 11 009 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 10 262", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.